Disease surveillance and the academic, clinical, and public health communities

Emerging Infectious Diseases

Volumn 9, Issue 7, 2003, Pages 781-787

  Pinner, Robert W ^a   Rebmann, Catherine A ^a   Schuchat, Anne ^a   Hughes, James M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

COMMUNITY; DRUG CONJUGATION; EVIDENCE BASED MEDICINE; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; INFECTION CONTROL; MEDICAL SOCIETY; NEWBORN PERIOD; PREVENTIVE HEALTH SERVICE; PROPHYLAXIS; PUBLIC HEALTH; REVIEW; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; UNITED STATES;

EID: 0038724910     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0907.030083     Document Type: Review

References (34)

1. Gerberding JL, Hughes JM, Koplan JP. Bioterrorism preparedness and response: clinicians and public health agencies as essential partners. JAMA 2002;287:898-90.
2. Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med 2002;137:173-9.
3. Centers for Disease Control and Prevention. West Nile virus activity - United States, September 26-October 2, 2002, and investigations of West Nile virus infections in recipients of blood transfusion and organ transplantation. MMWR Morb Mortal Wkly Rep 2002;51:884,895.
4. Institute of Medicine. Emerging infections: microbial threats to health in the United States. Washington: National Academy Press; 1992.
5. Centers for Disease Control and Prevention. Addressing emerging infectious disease threats: a prevention strategy for the United States. Atlanta: U.S. Department of Health and Human Services, Public Health Service; 1994.
6. Centers for Disease Control and Prevention. Preventing emerging infectious diseases: a strategy for the 21st Century. Atlanta: U.S. Department of Health and Human Services, Public Health Service; 1998.
7. Hardnett FP, Hoekstra RM, Kennedy MH, Angulo FJ, EIP Foodnet Working Group. Comparability of FoodNet and United States populations. Poster presented at: International Conference on Emerging Infectious Diseases; 24-27 March 2002; Atlanta, Ga.
8. Schuchat A, Hilger T, Zell E, Farley MM, Reingold A, Harrison L, et al. Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis 2001;7:92-9.
9. Centers for Disease Control and Prevention. Foodborne diseases active surveillance network. MMWR Morb Mortal Wkly Rep 1997;46:258-61.
10. Herikstad H, Yang S, Van Gilder TJ, Vugia D, Hadler J, Blake P, et al. A population-based estimate of the burden of diarrhoeal illness in the United States: FoodNet, 1996-7. Epidemiol Infect 2002;129:9-17.
11. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999;5:607-25.
12. Hajjeh RA, Relman D, Cieslak PR, Sofair AN, Passaro D, Flood J, et al. Surveillance for unexplained deaths and critical illnesses due to possibly infectious cases, United States, 1995-1998. Emerg Infect Dis 2002;8:145-53.
13. Perkins BA, Flood JM, Danila R, Holman RC, Reingold AL, Klug LA, et al. Unexplained deaths due to possibly infectious causes in the United States: defining the problem and designing surveillance and laboratory approaches. Emerg Infect Dis 1996;2:47-53.
14. Ijdo JW, Meek JI, Cartter ML, Magnarelli LA, Wu C, Tenuta SW, et al. Emergence of another tickborne infection in the 12-town area around Lyme, CT: human ehrlichiosis. J Infect Dis 2000;181:1388-93.
15. Centers for Disease Control and Prevention. Surveillance for Creutzfeldt-Jakob disease - United States. MMWR Morb Mortal Wkly Rep 1996;45:665-8.
16. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2000;49(RR-9):1-35.
17. Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA 2001;285:1729-35.
18. Centers for Disease Control and Prevention. Notice to readers: decreasing availability of pneumococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep 2001;50:783.
19. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennet NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348;1737-46.
20. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000;343:1917-24.
21. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the drug-resistant Pneumococcus pneumonia therapeutic working group. Arch Intern Med 2000;160:1399-408.
22. Schrag SJ, Zywicki S, Farley M, Reingold A, Harrison L, Lefkowitz L, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis: population-based surveillance in the United States, 1993-1998. N Engl J Med 2000;342:15-20.
23. Centers for Disease Control and Prevention. Early-onset group B streptococcal disease-United States, 1998-1999. MMWR Morb Mortal Wkly Rep 2000;49:793-6.
24. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9.
25. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from the CDC. MMWR Morb Mortal Wkly Rep 2002;51(RR-11):1-22.
26. Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A. Trends in the incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics 2002; 110:690-5.
27. Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001;108:1094-8.
28. Centers for Disease Control and Prevention. Preliminary FoodNet data on the incidence of foodborne illnesses - select sites, United States, 2001. MMWR Morb Mortal Wkly Rep 2002;51:325-9.
29. Centers for Disease Control and Prevention. Diagnosis and management of foodborne illnesses. MMWR Morb Mortal Wkly Rep 2001;50(RR-2):1-69.
30. Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994;331:546-8.
31. Zaki SR, Khan AS, Goodman RA, Armstrong LR, Greer PW, Coffield LM, et al. Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993: implications for emerging infectious diseases. Arch Pathol Lab Med 1996;120:134-9.
32. Park SY, Glaser C, Murray WJ, Kazacos KR, Rowley HA, Frederick DR, et al. Raccoon roundworm (Baylisascaris procyonis) encephalitis: case report and field investigation. Pediatrics 2000;106:e56.
33. Asnis DS, Conetta R, Teixeira AA, Waldman G, Sampson BA. The West Nile virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis 2000;30:413-8.
34. Centers for Disease Control and Prevention. Update: Clostridium novyi and unexplained illness among injecting drug users - Scotland, Ireland, and England, April-June 2000. MMWR Morb Mortal Wkly Rep 2000;49:543-5.